Details for Patent: 8,168,655
✉ Email this page to a colleague
Which drugs does patent 8,168,655 protect, and when does it expire?
Patent 8,168,655 protects XIIDRA and is included in one NDA.
This patent has thirty-five patent family members in fifteen countries.
Summary for Patent: 8,168,655
| Title: | Compositions and methods for treatment of eye disorders |
| Abstract: | The present invention provides compounds and methods for the treatment of LFA-1 mediated diseases. In particular, LFA-1 antagonists are described herein and these antagonists are used in the treatment of LFA-1 mediated diseases. One aspect of the invention provides for diagnosis of an LFA-1 mediated disease and administration of a LFA-1 antagonist, after the patient is diagnosed with a LFA-1 mediated disease. In some embodiments, the LFA-1 mediated diseases treated are dry eye disorders. Also provided herein are methods for identifying compounds which are LFA-1 antagonists. |
| Inventor(s): | Gadek; Thomas (Oakland, CA), Burnier; John (Pacifica, CA) |
| Assignee: | SARcode Bioscience Inc. (Brisbane, CA) |
| Application Number: | 11/436,906 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,168,655 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; Device; Delivery; |
Drugs Protected by US Patent 8,168,655
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb Inc | XIIDRA | lifitegrast | SOLUTION/DROPS;OPHTHALMIC | 208073-001 | Jul 11, 2016 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF SIGNS AND SYMPTOMS OF DRY EYE DISEASE (DED) | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,168,655
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2444079 | ⤷ Sign Up | C02444079/01 | Switzerland | ⤷ Sign Up |
| Australia | 2006247136 | ⤷ Sign Up | |||
| Canada | 2609053 | ⤷ Sign Up | |||
| Canada | 2960117 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
